Novus Biologicals™ DRAK2 Antibody Blocking Peptide

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the carboxy terminus of human DRAK2. Source: Synthetic (Accession #: AB011421) The DRAK2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 9262
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76885. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: DAP kinase-related apoptosis-inducing protein kinase 2, DRAK2death-associated protein kinase-related 2, EC 2.7.11, EC 2.7.11.1, serine/threonine kinase 17 b, serine/threonine kinase 17 b (apoptosis-inducing), serine/threonine-protein kinase 17 B
• Gene Symbol: STK17B
• Product Type: DRAK2
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino acids near the carboxy terminus of human DRAK2